{
  "id": 12710532,
  "title": "Why is Profound Medical stock surging today?",
  "url": "https://urgent.news/2026/10/07/why-is-profound-medical-stock-surging-today",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-07T20:43:26.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/why-is-profound-medical-stock-surging-today-93CH-4937522"
  },
  "original_language": "en",
  "account": "Profound Medical's stock experienced a significant surge of 19.0% in after-hours trading following the company's announcement of impressive preliminary revenue results for the third quarter of 2026. Analysts had predicted revenue between $9.8 million and $10.0 million, but Profound exceeded expectations by a substantial margin, reaching approximately 45% to 47% above the Bloomberg mean consensus of $6.78 million. The company's gross margin was also projected to surpass 70%, highlighting the positive trajectory of its business operations.\n\nThe magnitude of the beat was further amplified when considering the company's sequential performance. The preliminary Q3 figure represented a remarkable growth rate of 292% to 300% compared to Q2 2026, and around 85% to 89% growth year-over-year when compared to Q3 2025. CEO and Chairman Arun Menawat emphasized this as a historic milestone for Profound, attributing the surge to the expanding installed base and new customer accounts.\n\nDespite a generally subdued market mood, with major indices like the S&P 500, Dow Jones, and NASDAQ experiencing slight declines, Profound's strong performance stood out. Factors contributing to this positive sentiment included rising Treasury yields, reaching near 5.31% for the 10-year rate, and mounting anticipation of Federal Reserve minutes. These elements made the company's specific catalyst particularly compelling in comparison to other equities.\n\nCEO Menawat's reassurance through a statement highlighting sustained commercial momentum added further weight to the positive outlook. As a result, investors found substantial reasons to re-price the stock sharply higher. The after-hours trading propelled Profound Medical shares toward the upper half of their 52-week range, which spanned between $4.80 and $8.95. The article was produced with AI assistance and subsequently reviewed by an editor.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Profound Medical stock surges 20% on raised Q3 revenue outlook",
        "url": "https://urgent.news/2026/10/07/profound-medical-stock-surges-20-on-raised-q3-revenue-outlook",
        "published": "2026-10-07T21:32:49.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}